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Abstract 
Background: Indirect genetic diagnosis using polymorphic 
DNA markers can detect carriers of hemophilia A. This tech-
nique is preferable in developing countries because of its simplic-
ity and cost effectiveness compared to direct mutation analysis. 
In the present study, we examined usefulness of intragenic 
marker BclI restriction fragment length polymorphism (RFLP) at 
intron 18, for carrier detection. How this marker is informative 
was tested in 102 members of 16 hemophiliac families from Sis-
tan and Baluchestan province, Southeast of Iran. 
 
Methods: Blood samples were obtained from 29 hemophilia 
A patients and 73 of their relatives, after taking informed con-
sents. DNA was extracted using proteinase K digestion fol-
lowed by DNA precipitation. Factor VIII gene polymorphism 
was identified by the polymerase chain reaction/RFLP which 
is both sensitive and economical.  
 
Results: Our results showed that almost 69.8% of X-
chromosomes had restriction site for BclI enzyme. The het-
erozygosity rate for BclI polymorphism in tested women was 
61.4%, signifying the usefulness of this marker in carrier de-
tection. The informative rate respecting this polymorphism 
was 43.7% meaning that a remarkable percent of families 
from the target population could be diagnosed using this 
marker alone. 
 
Conclusion: In Sistan and Baluchestan province where there 
is limited access to sophisticated facilities of molecular diag-
nosis, use of PCR-based analysis of DNA polymorphism in 
the BclI locus can be used to identify a remarkable percentage 
of the carriers and even for prenatal diagnosis.  Meanwhile, it 
is necessary to evaluate the effectiveness of other polymorphic 
DNA markers to enhance the informative rate. 
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Introduction 
emophilia A, an X-linked recessive disorder, is char-
acterized by a deficiency in the activity of coagulation 
factor VIII. Generally, substitution therapy with factor H 
 
 
 
 
A. Zadeh-Vakili, P. Eshghi1,  
Gh. Rastegar Lari2 
 
 
 
 
 
 
 
 
 
 
 
 
 
Department of Genetics,  
Thalassemia Prenatal Diagnosis Center, 
Zahedan University of Medical sciences, 
Zahedan, Iran. 
1Department of Pediatrics  
Hematology-Oncology,  
Mofid Hospital,  
Shahid Beheshti University of Medical 
sciences, Tehran, Iran. 
2Department of Hematology,  
School of Medicine,  
Iran University of Medical Sciences, 
Tehran, Iran. 
 
Correspondence: 
Azita Zadeh-Vakili PhD, 
Ali-e-Asghar Hospital,  
Thalassemia Prenatal Diagnosis Center,  
Zahedan University of Medical sciences, 
Zahedan, Iran. 
Tel/Fax: +98 541 3218998 
Email: Azitavakili@gmail.com  
 
Original Article 
A. Zadeh-Vakili, P. Eshghi, Gh. Rastegar Lari 
 
Iran J Med Sci March 2008; Vol 33 No 1 34 
VIII is satisfactory, but cost constraint is a ma-
jor problem in developing countries. Therefore, 
carrier detection and prenatal diagnosis is use-
ful in these countries and play an important 
role in limiting the propagation of the disease. 
Genetic diagnosis of hemophilia A using 
polymorphic DNA markers can detect carriers 
of hemophilia A. This is preferable in develop-
ing countries because of its simplicity and cost 
effectiveness compared to direct mutation 
analysis. Many polymorphic markers within 
and near the factor VIII gene have been re-
ported as being useful for the carrier detection 
and prenatal diagnosis. These markers include 
BclI/intron 18 polymorphism,1 XbaI/intron 22 
polymorphism,2,3 intron 13/22 dinucleotide re-
peat polymorphism,4 and extragenic St14 vari-
able number tandem repeat (VNTR).5 Of these, 
BclI is the most widely used marker.1,3,6-9 
The allele frequencies in a given factor VIII 
restriction fragment length polymorphism (RFLP) 
differ significantly in various ethnic groups.3,9,10 
Therefore, the clinical usefulness of a DNA 
polymorphism should be determined according 
to ethnicity of the population under study. 
“Sistan and Baluchestan” is a province lo-
cated in southeastern Iran, where the preva-
lence of hemophilia A is about eight per 
100,000 among male population and the so-
cioeconomic condition of the local population is 
well below the average for the country. 
In this study, we examined whether poly-
merase chain reaction (PCR)-based analysis 
of DNA polymorphism in the BclI locus was 
efficient enough for carrier detection in the 
population of Sistan and Baluchestan. 
 
Materials and Methods 
 
After taking informed concents, blood samples 
(10 mL) collected in EDTA tubes were ob-
tained from 29 patients with hemophilia A and 
73 of their relatives including parents and sis-
ters who wished to be tested. DNA was ex-
tracted using proteinase K digestion followed 
by DNA precipitation. 
The BclI polymorphism was analyzed by 
restriction enzyme-PCR. PCR was performed 
by adding 0.1–0.5 mg of DNA to 50 mL PCR 
reaction mixture consisting of 50 mM KCl, 10 
mM Tris HCl [pH 8.3], 1.5 mM MgCl2, 50 mM of 
each dNTP, and 0.5mM of each primer and one 
U of Taq polymerase. The sequence of primers 
used is given in table 1. 
After five min at 95 °C for initial denatura-
tion, 30 cycles of PCR were performed (dena-
turation: one min at 95 °C; annealing: one min 
at 50 °C; extension: one min at 72 °C) with an 
automated thermal cycler. Then, 26 mL of am-
plified product was digested with BclI restric-
tion enzyme at 55 °C for 2 h. Amplicons (be-
fore and after treatment with restriction en-
donuclease) were submitted to agarose gel 
electrophoresis and stained with ethidium bro-
mide. For characterization of molecular size in 
electrophoresis, фX174 DNA digested with 
HaeIII was used as marker. The sizes of the 
fragments generated are given in table 1. 
 
Results 
 
One-hundred and two individuals from 16 fami-
lies, comprised of 29 hemophiliacs, 16 unaf-
fected males, 16 obligate carriers and 41 pos-
sible carriers, were sampled for the present 
study. According to the pedigree analysis, 14 
out of these 16 families had a history of hemo-
philia A. The results of restriction enzyme-PCR 
analysis for one of these families with two af-
fected sons, are shown in figure 1. Summary of 
the results related to the analysis of BclI poly-
morphic site is given in table 2. Of the women 
tested for the above-mentioned polymorphism, 
61.4% were found to be heterozygous. As ob-
ligate carriers with X-linked alleles are useful 
for pedigree analysis, the above percentage 
justifies the usefulness of BclI marker in detec-
tion of the carrier state.  Indeed, 43.7% of fami-
lies could be diagnosed using this marker 
alone. Of 41 possible carriers, seven women 
Table 1: Primers used for the analysis of factor VIII gene BclI  polymorphism.7 
Primers Sequence 5¢–3¢ PCR product size  
(bp) 
Absence of site  
(bp) 
presence of site  
(bp) 
BclI forward TAA AAG CTT TAA ATG GTC TAG GC 
 
BclI reverse TTC GAA TTC TGA AAT TAT CTT GTT C 
142 142  
(−) 
99 and 43  
(+) 
 
 
Table 2: Allele frequencies of BclI RFLP 
 Allele frequencies (%)a   
Number of X  
Chromosomes 
+ − Heterozygosity rate 
(%)b 
Informative families 
(%) 
159 69.8 30.2 61.4 43.7% 
a frequency refers to the number of alleles detected divided by the total number of alleles analyzed. 
b heterozygosity refers to the percentage of women found to be heterozygous for the polymorphism among the total num-
ber of women analyzed. 
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were diagnosed as carrier and 10 as non-
carriers. The prevalence of a ‘+’ allele for BclI 
restriction (allele digested by BclI) in the stud-
ied population was found to be 69.8%. 
 
 
Figure 1: Alleles of intragenic BclI RFLP in a hemophilic 
family. 
Lane 1: HaeIII digested фX174 DNA size marker.  Lanes 
2–4: −/+ ,+/+ and −/− controls, respectively.  Lanes 5–6: 
affected sons.  Lane 7: unaffected father.  Lane 8: mother 
(obligate carrier). Lanes 9–12: sisters.  Three out of four 
sisters (lanes 9, 11 and 12) are carriers and one of them 
(lane 10) is diagnosed as non-carrier. 
 
Discussion 
 
In developing countries like Iran, carrier detec-
tion and prenatal diagnosis of hemophilia will 
be a great step forward in reducing the burden 
of hemophilia care in the society. However, 
direct diagnosis of the molecular defects in 
hemophilia is often difficult, due to the high 
heterogeneity of mutations and the size and 
structural complexity of the factor VIII gene, so 
linkage analysis with RFLP is the most useful 
approach.11,12 
Since Iran is a country with a population 
composed of a wide variety of ethnic groups, 
acquiring data about genetic variations in dif-
ferent regions of the country should be of great 
help for assuming a suitable strategy for diag-
nosing the carriers, and also for prenatal diag-
nosis. In this context a few studies have been 
performed in the country and their results indi-
cated the usefulness of RFLP analyses in de-
tection of hemophilia A carriers.13,14 
The preliminary study to estimate the het-
erozygosity for BclI locus in the target popula-
tion, showed a rate of 61.4% which is signifi-
cantly higher than the similar rates in other 
populations; the rate is 42% in whites, 21% in 
Koreans, and 26.5% in Japanese.1,3,15 The ob-
served rate also differs significantly from what 
has been reported from other parts of the 
country, i.e., 48% and 28.57%.13,14 On the 
other hand it is almost the same as the rates 
obtained from some parts of India, especially 
the northern areas of that country which have 
had rates as high as 58%–60% in various stud-
ies.8,9,16 It should be mentioned that based on 
our previous experiments, the studied popula-
tion, also showed notable resemblance with 
Indian population in some other mutations and 
haplotypes including the more common muta-
tions for β-thalassemia. The informative rate 
respecting this polymorphism was 43.7% which 
confirmed the efficiency of BclI RFLP in detect-
ing carriers in the population studied. This find-
ing is in accordance with the reported findings 
from an identical study on a sample population 
composed of families who were referred from 
different parts of Iran.13 The efficiency of BclI 
RFLP in detecting carriers varies in different 
ethnic groups— 25.9% in Koreans, 41% in 
American whites and 64% in Indians.3,8,17 
Although the informative rate of 43.7% 
achieved in our study is quite helpful in detect-
ing the carrier state, other studies have shown 
that by using 3–4 markers simultaneously, the 
carrier state can be determined in about 80% 
of the affected families.8,18 Therefore, the next 
step to assign the strategy of detecting carriers 
and prenatal diagnosis would be to investigate 
the informative rate of other polymorphic 
markers. Among the available markers, the 
intragenic markers are preferable in view of 
their high accuracy in diagnosis and also be-
cause their risk of error due to miotic recombi-
nation is less than 1%.19 
In conclusion, analysis of BclI polymor-
phism is effective and feasible in carrier detec-
tion and we suggest it for carrier screening and 
prenatal diagnosis in hemophilic families. To 
be capable of detecting carriers in more fami-
lies, utilizing other RFLP sites would be helpful. 
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